Yubo International Biotech Stock Performance
| YBGJ Stock | USD 0.07 0.0001 0.15% |
On a scale of 0 to 100, Yubo International holds a performance score of 7. The firm maintains a market beta of 1.59, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Yubo International will likely underperform. Please check Yubo International's jensen alpha, semi variance, price action indicator, as well as the relationship between the maximum drawdown and daily balance of power , to make a quick decision on whether Yubo International's historical returns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Yubo International Biotech are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain technical and fundamental indicators, Yubo International revealed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 1000.00 | |
| Total Cashflows From Investing Activities | -564.7 K |
Yubo |
Yubo International Relative Risk vs. Return Landscape
If you would invest 5.00 in Yubo International Biotech on December 17, 2024 and sell it today you would earn a total of 1.79 from holding Yubo International Biotech or generate 35.8% return on investment over 90 days. Yubo International Biotech is currently generating 0.7204% in daily expected returns and assumes 7.1737% risk (volatility on return distribution) over the 90 days horizon. In different words, 63% of pink sheets are less volatile than Yubo, and 86% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Yubo International Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Yubo International's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Yubo International Biotech, and traders can use it to determine the average amount a Yubo International's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1004
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | YBGJ | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.17 actual daily | 63 63% of assets are less volatile |
Expected Return
| 0.72 actual daily | 14 86% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Yubo International is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Yubo International by adding it to a well-diversified portfolio.
Yubo International Fundamentals Growth
Yubo Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Yubo International, and Yubo International fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Yubo Pink Sheet performance.
| Return On Equity | -20.23 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (4.59) % | |||
| Current Valuation | 14.08 M | |||
| Shares Outstanding | 119.82 M | |||
| Price To Book | 61.23 X | |||
| Price To Sales | 26.55 X | |||
| Revenue | 1.24 B | |||
| EBITDA | (1.54 B) | |||
| Cash And Equivalents | 36.58 K | |||
| Total Debt | 2.4 M | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (1.02 M) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 4.59 K | |||
About Yubo International Performance
By evaluating Yubo International's fundamental ratios, stakeholders can gain valuable insights into Yubo International's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Yubo International has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Yubo International has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Yubo International Biotech Limited, thorough its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. Yubo Intl is traded on OTC Exchange in the United States.Things to note about Yubo International performance evaluation
Checking the ongoing alerts about Yubo International for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Yubo International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Yubo International is way too risky over 90 days horizon | |
| Yubo International has some characteristics of a very speculative penny stock | |
| Yubo International appears to be risky and price may revert if volatility continues | |
| Yubo International has high likelihood to experience some financial distress in the next 2 years | |
| Yubo International Biotech currently holds 2.4 M in liabilities. Yubo International has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Yubo International until it has trouble settling it off, either with new capital or with free cash flow. So, Yubo International's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Yubo International sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Yubo to invest in growth at high rates of return. When we think about Yubo International's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 1.24 B. Net Loss for the year was (1.54 B) with profit before overhead, payroll, taxes, and interest of 820.65 K. | |
| Yubo International Biotech currently holds about 36.58 K in cash with (1.02 M) of positive cash flow from operations. | |
| Roughly 95.0% of the company outstanding shares are owned by insiders |
- Analyzing Yubo International's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Yubo International's stock is overvalued or undervalued compared to its peers.
- Examining Yubo International's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Yubo International's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Yubo International's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Yubo International's pink sheet. These opinions can provide insight into Yubo International's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Yubo Pink Sheet
Yubo International financial ratios help investors to determine whether Yubo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Yubo with respect to the benefits of owning Yubo International security.